Corrigendum: State of play in the molecular presentation and recognition of anti-tumor lipid-based analogues
T. Praveena, Jérôme Le Nours
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1- —Australian Research Council 10.13039/501100000923
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer, Lipids, and Metabolism
In the published article, there was an error in Figure 2 as published. In Figure 2B, the annotations for the last two ternary structures (last 2 panels) were inverted, namely, (iNKT TCR-mCD1d-PyrC-α-GalCer - PDB code: 4IRS) and (iNKT TCR-mCD1d-EF77 - PDB code: 4Y4K) were inadvertently swapped. The corrected Figure 2 and its caption appear below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.